Is Livongo-Teladoc merger a ‘leap forward’ for digital health?
pharmaphorum
AUGUST 18, 2020
While both companies operate in virtual care and chronic condition management, their approaches are very different. Its second-quarter revenue leaped 125% to almost $92 million.
Let's personalize your content